ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements with these filters
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.
Amrutanjan Health Care Limited submitted its 89th Annual Report for the financial year 2025-26. The company scheduled its Annual General Meeting for September 23, 2026.
Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.
Amrutanjan Health Care Limited has fixed September 11, 2026, as the record date for the payment of the final dividend for the financial year 2025-26.
Amrutanjan Health Care Ltd reported revenue from operations of ₹103 Cr (+9.6% YoY) and net profit of ₹4.4 Cr (-47.0% YoY) for Q1 FY27.
Amrutanjan Health Care Ltd explained a delay in filing a credit rating disclosure due to the unavailability of the Key Managerial Personnel.
Amrutanjan Health Care Limited has scheduled a Board meeting on August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Amrutanjan Health Care has commenced commercial operations at its new Greenfield Sanitary Napkin Manufacturing Facility in Telangana. This marks a significant manufacturing capacity expansion.
Amrutanjan Health Care has commissioned a new ₹150 crore greenfield sanitary napkin manufacturing facility in Telangana. The plant features a 700 million annual unit capacity.
CARE Ratings has assigned a 'CARE A; Stable' issuer rating to Amrutanjan Health Care Limited. The rating reflects the company's established brand and debt-free capital structure.
DSP Mutual Fund schemes sold 2,11,361 shares of Amrutanjan Health Care Limited in the open market. This transaction reduced their stake from 3.55% to 2.82%.
Amrutanjan Health Care paid ₹9.75 Crore as lease rent arrears to Kapaleeswarar Temple, complying with a Madras High Court order.
Amrutanjan Health Care filed a SEBI DP Regulation 74(5) compliance certificate confirming dematerialisation and cancellation of securities for Q1 2026. No financial impact.